Gerber Kawasaki Wealth & Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $726K | Sell |
1,789
-260
| -13% | -$105K | 0.03% | 167 |
|
2025
Q1 | $1.02M | Sell |
2,049
-24
| -1% | -$11.9K | 0.05% | 136 |
|
2024
Q4 | $1.08M | Sell |
2,073
-83
| -4% | -$43.2K | 0.05% | 136 |
|
2024
Q3 | $1.33M | Sell |
2,156
-118
| -5% | -$73K | 0.06% | 123 |
|
2024
Q2 | $1.26M | Sell |
2,274
-317
| -12% | -$175K | 0.06% | 123 |
|
2024
Q1 | $1.51M | Sell |
2,591
-791
| -23% | -$460K | 0.08% | 115 |
|
2023
Q4 | $1.8M | Sell |
3,382
-983
| -23% | -$522K | 0.11% | 104 |
|
2023
Q3 | $2.21M | Sell |
4,365
-859
| -16% | -$435K | 0.15% | 89 |
|
2023
Q2 | $2.72M | Sell |
5,224
-182
| -3% | -$94.9K | 0.18% | 84 |
|
2023
Q1 | $3.12M | Sell |
5,406
-908
| -14% | -$523K | 0.25% | 74 |
|
2022
Q4 | $3.48M | Sell |
6,314
-1,051
| -14% | -$579K | 0.31% | 69 |
|
2022
Q3 | $3.75M | Buy |
7,365
+187
| +3% | +$95.3K | 0.35% | 58 |
|
2022
Q2 | $3.9M | Sell |
7,178
-167
| -2% | -$90.7K | 0.37% | 58 |
|
2022
Q1 | $4.34M | Sell |
7,345
-54
| -0.7% | -$31.9K | 0.35% | 49 |
|
2021
Q4 | $4.89M | Buy |
7,399
+1,088
| +17% | +$719K | 0.39% | 49 |
|
2021
Q3 | $3.61M | Buy |
6,311
+2,075
| +49% | +$1.19M | 0.47% | 39 |
|
2021
Q2 | $2.14M | Buy |
4,236
+544
| +15% | +$274K | 0.22% | 75 |
|
2021
Q1 | $1.68M | Buy |
3,692
+671
| +22% | +$306K | 0.2% | 77 |
|
2020
Q4 | $1.41M | Buy |
3,021
+427
| +16% | +$199K | 0.19% | 70 |
|
2020
Q3 | $1.15M | Buy |
2,594
+113
| +5% | +$49.9K | 0.24% | 56 |
|
2020
Q2 | $898K | Sell |
2,481
-455
| -15% | -$165K | 0.2% | 68 |
|
2020
Q1 | $832K | Buy |
+2,936
| New | +$832K | 0.24% | 65 |
|